Summit Therapeutics Plc

Summit Corporation Plc

Vida Pharma Limited

Francis Xavier Wilson

Peter David Johnson

Colin Richard Dorgan

Richard Storer

Graham Michael Wynne

Olivier De Moor

Alan Geoffrey Roach

Richard Vickers

Paul James Davis

Stephen Paul Wren

Richard John Vickers

Lauren Jayne Sudlow

Renate Maria Van Well

Jean-Francois Carniaux

Robert James Nash

Graeme Horne

Collin Richard Dorgan

Described are compositions comprising imino sugar acids for the treatment of energy utilization disease (e.g. metabolic syndrome, including any disease or disorder associated therewith, for example central obesity, elevated levels of triglycerides and diabetes, including type 1 diabetes, type 2 diabetes and insulin resistance), processes for producing said compositions from various plant sources, together with various products, compounds, compositions, medical uses and methods based thereon.

Treatment of energy utilization disease

Disclosed are compounds of formula (I): which are of use in the treatment of bacterial diseases and infections, to compositions containing those compounds and to methods of treating bacterial diseases and infections using the compounds. In particular, the compounds are useful for the treatment of infection with, and diseases caused by,

Antibacterial compounds

Disclosed are compounds of formula (I): and pharmaceutically acceptable N-oxides, salts, hydrates, solvates, complexes, bioisosteres, metabolites, and prodrugs thereof, which are of use in the treatment of infection with, and diseases caused by,

[object Object]

Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by,

Disclosed are compounds of formula (I), which are of use in the treatment of bacterial diseases and infections, to compositions containing those compounds and to methods of treating bacterial diseases and infections using the compounds. In particular, the compounds are useful for the treatment of infection with, and diseases caused by,. 

Growing community of inventors

Abingdon, United Kingdom

Francis Xavier Wilson